dc.contributor.author |
Akyol, Selahattin |
|
dc.contributor.author |
Celik, Mehmet |
|
dc.contributor.author |
Cersit, Sinan |
|
dc.contributor.author |
Dereli, Seckin |
|
dc.contributor.author |
Eren, Hayati |
|
dc.contributor.author |
Gursoy, Mustafa Ozan |
|
dc.contributor.author |
Keskin, Muhammed |
|
dc.contributor.author |
Kup, Ayhan |
|
dc.contributor.author |
Ocal, Lutfi |
|
dc.contributor.author |
Turkmen, Mehmet Muhsin |
|
dc.date.accessioned |
2022-08-17T05:28:52Z |
|
dc.date.available |
2022-08-17T05:28:52Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
http://doi.org/10.1007/s10554-020-02078-y |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2297 |
|
dc.description.abstract |
The CHA(2)DS(2)-VASc score predicts stroke and mortality risk in several cardiovascular diseases regardless of atrial fibrillation. In this study, we aimed to investigate the ability of CHA(2)DS(2)-VASc score to predict in-hospital and long-term outcomes in patients undergoing carotid artery stenting (CAS). The study population included 558 patients undergoing CAS. The patients were stratified into three groups based on their CHA(2)DS(2)-VASc scores [low (<= 2, n = 123), moderate (3-5, n = 355) and high (6-8, n = 80)]. In-hospital and 3-year outcomes were compared between the groups. In-hospital rates of ipsilateral and major strokes and death were significantly different between the groups (1.6% vs. 3.9% vs. 16.2%; 1.6% vs. 4.5% vs. 16.2%; 0.8% vs. 3.1% vs. 13.8%, p < 0.001 for all, respectively). At 3 years of follow-up, rates of ipsilateral and major strokes and death were significantly increased in patients with highscore compared to those with moderate and low scores (1.6% vs. 5.8% vs. 13%, p = 0.005; 0.8% vs. 5.2% vs. 13%, p = 0.001; 1.6% vs. 8.4% vs. 15.9%; p = 0.002, respectively). After adjusting for multi-model Cox regression analysis, CHA(2)DS(2)-VASc score persisted as an independent prognostic factor for mortality and major stroke in patients undergoing CAS. Higher CHA(2)DS(2)-VASc score predicted increased risk of in-hospital and 3- year stroke and mortality in patients undergoing CAS. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING |
en_US |
dc.relation.isversionof |
10.1007/s10554-020-02078-y |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
CHA(2)DS(2)-VASc score; Carotid stenting; Mortality; Stroke |
en_US |
dc.title |
Usefulness of CHA(2)DS(2)-VASc Score to predict clinical outcomes of patients undergoing carotid artery stenting |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
SPRINGER, VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.contributor.authorID |
0000-0003-0090-3835 |
en_US |